Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Shih

Showing results (261-270 of 277) with videos related to

Pageof 28
Sort By:
Gut|May 16, 2007
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinomaY-C Chou, M-W Yu, C-F Wu, et al.
Lancet (London, England)|June 8, 2026
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trialVanita R Aroda, Melanie J Davies, Jill Maaske, et al.
Human Mutation|May 2, 2000
Novel mutations in 13 probands with galactokinase deficiencyV Kolosha, E Anoia, C de Cespedes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2022
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variantGregory S Sawicki, Mark Chilvers, John McNamara, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 10, 2011
Rubella seroepidemiology and estimations of the catch-up immunisation rate and persistence of antibody titers in pregnant women in TaiwanC-C Lin, C-Y Yang, Y-L Shih, et al.
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|May 1, 1979
A survey and follow-up study of anicteric hepatitis, other asymptomatic liver diseases and hepatitis B surface antigen carriersJ L Sung, P L Shih, Y F Liaw, et al.
Nature Communications|October 19, 2021
Palmitoylation targets the calcineurin phosphatase to the phosphatidylinositol 4-kinase complex at the plasma membraneIdil Ulengin-Talkish, Matthew A H Parson, Meredith L Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Nodulisporic acid side-chain modifications: access to the 2", 3", 4", and 6" registersPrasun K Chakravarty, Thomas L Shih, Steven L Colletti, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Chemical modification of nodulisporic acid A: preliminary structure-activity relationshipsP T Meinke, M B Ayer, S L Colletti, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
Side-chain homologation of nodulisporic acid: synthesis of potent new dienyl derivativesDong Ok, Chunshi Li, Thomas L Shih, et al.
Pageof 28

Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Gut|May 16, 2007
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinomaY-C Chou, M-W Yu, C-F Wu, et al.
Lancet (London, England)|June 8, 2026
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trialVanita R Aroda, Melanie J Davies, Jill Maaske, et al.
Human Mutation|May 2, 2000
Novel mutations in 13 probands with galactokinase deficiencyV Kolosha, E Anoia, C de Cespedes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2022
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variantGregory S Sawicki, Mark Chilvers, John McNamara, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 10, 2011
Rubella seroepidemiology and estimations of the catch-up immunisation rate and persistence of antibody titers in pregnant women in TaiwanC-C Lin, C-Y Yang, Y-L Shih, et al.
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|May 1, 1979
A survey and follow-up study of anicteric hepatitis, other asymptomatic liver diseases and hepatitis B surface antigen carriersJ L Sung, P L Shih, Y F Liaw, et al.
Nature Communications|October 19, 2021
Palmitoylation targets the calcineurin phosphatase to the phosphatidylinositol 4-kinase complex at the plasma membraneIdil Ulengin-Talkish, Matthew A H Parson, Meredith L Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Nodulisporic acid side-chain modifications: access to the 2", 3", 4", and 6" registersPrasun K Chakravarty, Thomas L Shih, Steven L Colletti, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Chemical modification of nodulisporic acid A: preliminary structure-activity relationshipsP T Meinke, M B Ayer, S L Colletti, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
Side-chain homologation of nodulisporic acid: synthesis of potent new dienyl derivativesDong Ok, Chunshi Li, Thomas L Shih, et al.
Pageof 28